Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 (Cancer Gene Therapy, (2014), 21, 7, (290-296), 10.1038/cgt.2014.29)

doi:10.1038/s41417-023-00672-5

科研成果详情

名称	Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 (Cancer Gene Therapy, (2014), 21, 7, (290-296), 10.1038/cgt.2014.29)
作者	Gan R.1; Yang Y.1; Yang X.1; Zhao L.1; Lu J.1,2,3; Meng Q.H.4
发表期刊	Cancer Gene Therapy;
语种	英语
原始文献类型	Erratum
摘要	Correction to: Cancer Gene Ther, published online 13 June 2014 Following the publication of this article, the authors noted that the panel in Figure 1b for AS-miR-221 had mistakenly been placed to show AS-miR-221/222. The correct panel for AS-miR-221/222 has now been included in the below revised figure. The conclusions of the article are unaffected by this correction. (Figure presented.) The original article has been corrected.
出版者	Springer Nature
ISSN	0929-1903
EISSN	1476-5500
卷号	30
期号	11
DOI	10.1038/s41417-023-00672-5
收录类别	SCOPUS
发布日期	2023-11-01
URL	查看原文
PubMed ID	37789076
通讯作者地址	[Lu J.]Wenzhou Medical University School of Laboratory Medicine and Life Sciences,Wenzhou,China ; [Meng Q.H.]Department of Laboratory Medicine,The University of Texas MD Anderson Cancer,Houston,United States
Scopus学科分类	Molecular Medicine;Molecular Biology;Cancer Research
SCOPUSEID	SCOPUS_ID:85173111677
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/184876
专题	检验医学院（生命科学学院、生物学实验教学中心）
通讯作者	Lu J.; Meng Q.H.
作者单位	1.Wenzhou Medical University School of Laboratory Medicine and Life Sciences,Wenzhou,China; 2.Key Laboratory of Laboratory Medicine,Ministry of Education,Wenzhou,China; 3.Zhejiang Provincial Key Laboratory of Medical Genetics,Wenzhou,China; 4.Department of Laboratory Medicine,The University of Texas MD Anderson Cancer,Houston,United States
第一作者单位	检验医学院（生命科学学院、生物学实验教学中心）
通讯作者单位	检验医学院（生命科学学院、生物学实验教学中心）
推荐引用方式 GB/T 7714	Gan R.,Yang Y.,Yang X.,et al. Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 (Cancer Gene Therapy, (2014), 21, 7, (290-296), 10.1038/cgt.2014.29). 2023.